Company Filing History:
2 out of 1,745 
1 out of 321 
1 out of 109 
Years Active: 2012-2021
Title: The Innovations of Erick Denamur
Introduction
Erick Denamur is a notable inventor based in Paris, France. He has made significant contributions to the field of bacteriophage research, particularly in addressing antibiotic resistance. With a total of 2 patents, his work is crucial in the ongoing battle against resistant bacterial strains.
Latest Patents
One of Denamur's latest patents is focused on a bacteriophage strain capable of producing a lytic infection in the ST131-025b:H4 clone. This invention is particularly relevant as the burden of the ST131-025b:H4 clonal complex in human communities and hospital-acquired infections is increasing worldwide. The bacteriophage LM33_P1, which he developed, infects exclusively 025b strains with 70% coverage on the two major antibiotic-resistant pandemic clonal complexes, ST131-025b:H4 and ST69-025b. The in vivo activity of bacteriophage LM33_P1 was evaluated using three different extraintestinal virulence murine models, demonstrating its ability to infect bacteria in several organs. This invention includes a polypeptide corresponding to the bacteriophage tail fiber protein, which is responsible for the attachment of the bacteriophage to the ST131-025b:H4 clone.
Career Highlights
Denamur has worked with prestigious institutions such as the Institut National de la Santé et de la Recherche Médicale and Assistance Publique-Hôpitaux de Paris. His research has been pivotal in understanding and combating antibiotic resistance through innovative bacteriophage applications.
Collaborations
Throughout his career, Denamur has collaborated with notable colleagues, including Olivier Clermont and Tony Le Gall. Their combined expertise has contributed to advancements in the field of bacteriophage research.
Conclusion
Erick Denamur's work exemplifies the importance of innovation in addressing critical health challenges, particularly antibiotic resistance. His contributions through patents and collaborations continue to pave the way for future advancements in medical research.